GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Jia Jie Biomedical Co Ltd (ROCO:4109) » Definitions » Gross Profit

Jia Jie Biomedical Co (ROCO:4109) Gross Profit : NT$173.3 Mil (TTM As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Jia Jie Biomedical Co Gross Profit?

Jia Jie Biomedical Co's gross profit for the three months ended in Dec. 2024 was NT$42.7 Mil. Jia Jie Biomedical Co's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was NT$173.3 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Jia Jie Biomedical Co's gross profit for the three months ended in Dec. 2024 was NT$42.7 Mil. Jia Jie Biomedical Co's Revenue for the three months ended in Dec. 2024 was NT$130.5 Mil. Therefore, Jia Jie Biomedical Co's Gross Margin % for the quarter that ended in Dec. 2024 was 32.72%.

Jia Jie Biomedical Co had a gross margin of 32.72% for the quarter that ended in Dec. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Jia Jie Biomedical Co was 37.28%. The lowest was 15.43%. And the median was 33.42%.


Jia Jie Biomedical Co Gross Profit Historical Data

The historical data trend for Jia Jie Biomedical Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jia Jie Biomedical Co Gross Profit Chart

Jia Jie Biomedical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.71 83.77 116.51 117.64 173.35

Jia Jie Biomedical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.22 50.99 48.75 30.92 42.69

Competitive Comparison of Jia Jie Biomedical Co's Gross Profit

For the Packaged Foods subindustry, Jia Jie Biomedical Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jia Jie Biomedical Co's Gross Profit Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Jia Jie Biomedical Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Jia Jie Biomedical Co's Gross Profit falls into.


;
;

Jia Jie Biomedical Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Jia Jie Biomedical Co's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=537.07 - 363.722
=173.3

Jia Jie Biomedical Co's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=130.459 - 87.768
=42.7

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$173.3 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Jia Jie Biomedical Co's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=42.7 / 130.459
=32.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Jia Jie Biomedical Co  (ROCO:4109) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Jia Jie Biomedical Co had a gross margin of 32.72% for the quarter that ended in Dec. 2024 => Competition eroding margins


Jia Jie Biomedical Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Jia Jie Biomedical Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Jia Jie Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
Jiuru 1st Road, 3rd Floor, No. 61, Sanmin District, Kaohsiung City, TWN, 807
Jia Jie Biomedical Co Ltd is a Taiwan-based company. It is engaged in the turtle shellfish, turtle eggs, turtle oil and other turtle food processing manufacturing sales trading business. It has two reportable segments: Taiwan Operating Segment and Mainland China Operating Segment. The Taiwan Operating Segment is mainly engaged in production and distribution segment of nutritional health products and insurance brokerage, while the Mainland China Operating Segment is mainly engaged in the sale of water purification equipment and related parts.

Jia Jie Biomedical Co Headlines

No Headlines